Dentists in Andover, MN Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Ethan R Chute, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3480 Bunker Lake Blvd Nw, Andover, MN 55304 Phone: 763-427-4780 |
Dr. Thomas Richard Swenson-bellson, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 13841 Round Lake Blvd Nw, Andover, MN 55304 Phone: 763-427-0285 Fax: 763-576-0156 |
 Tamara Smith, D.D.S., M.S.D Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 4187 161st Ln Nw, Andover, MN 55304 Phone: 651-303-8041 Fax: 651-303-8041 |
Dr. John Edward Ewert, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1573 154th Ave Nw, Suite 107, Andover, MN 55304 Phone: 763-786-3112 Fax: 763-786-3139 |
Dr. Holly Hill, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3480 Bunker Lake Blvd Nw Ste 202, Andover, MN 55304 Phone: 763-427-4780 Fax: 763-427-8471 |
News Archive
Taste receptors act as first line sentinels against infection in upper airway
The body uses mucus as a protective barrier to defend against pathogens, toxins, and allergens in the upper respiratory tract that can lead to such conditions as chronic sinusitis.
Most genetic abnormalities shared across multiple cancers
An international team of researchers has created a genome-scale map of 26 different cancers, revealing more than 100 genomic sites where DNA from tumors is either missing or abnormally duplicated compared to normal tissues. The study, the largest of its kind, finds that most of these genetic abnormalities are not unique to one form of cancer, but are shared across multiple cancers. The work appears in the February 18 issue of the journal Nature.
SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model.
Agena Bioscience acquires Sequenom's Bioscience business
Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc., which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories.
› Verified 8 days ago
Occupational Therapists
Counselors
Pharmacists
Clinical Social Workers
Dentists
Psychologists